Form 4 for DGX Quest Diagnostics
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-21 · accession 0001022079-24-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-23 | 2024-02-21 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $125.02 | -407 | 40.9K | -1.0% | -$50.9K | |
| 2024-02-23 | 2024-02-22 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $126.14 | -661 | 40.2K | -2% | -$83.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | F | D | 407 | $125.02 | 40,867 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. |
| 2 | Common | Common Stock | 2024-02-22 | S | D | 661 | $126.14 | 40,206 | D | — | — |